top of page

What We Do

How We Operate

How We Do It!

  • AI and ML Integration: We utilize advanced AI and ML algorithms to analyze complex biological data, revealing insights that were previously unattainable.

  • Transcriptomic and Proteomic Analysis: By examining the intricate details of gene expression and protein interactions, we identify novel targets that can lead to the development of new therapies.

  • Pathway Validation: Our technology not only discovers new targets but also validates existing pathways, ensuring the reliability and effectiveness of potential treatments.

 

We have developed a range of novel approaches
Our I3 platform (“Intuitive Informed Intelligence”) is proven. Our work over the last 18 years demonstrates clearly that these non-linear discovery tools are highly suited to the analysis of complex biological data 

​

Outcomes
The I3 platform identifies the most influential markers in a biological system, confirms their direction of influence and the relevant known drugs or chemical library hits: we find the molecular drivers of a given phenotype, leading to identification of new drug and diagnostic targets as well as new applications for existing drugs.

​

How We Work with Our Clients

  • Collaborative working on a shared risk and reward basis

  • Contract – a Fee for the service provided

  • Partnership – to develop Intellectual Property created by Intellomx technology, on a Licensing or Joint Venture basis

bottom of page